Avatrombopag in adults with immune thrombocytopenia: A multicentre real-life observational study in Madrid, Spain (AVAMAD study)

被引：0

作者：

Pascual-Izquierdo, Cristina ^{[1
]}

Llacer-Ferrandis, Ma. Jose ^{[1
]}

de-la-Iglesia, Almudena ^{[2
]}

Monsalvo-Saornil, Silvia ^{[2
]}

Menor-Gomez, Maria ^{[3
]}

Gil-Fernandez, Juan Jose ^{[3
]}

Chica-Gullon, Esther ^{[4
]}

alvarez-Roman, Maria Teresa ^{[5
]}

Perez-Segura, Gloria ^{[6
]}

Zafra, Denis ^{[6
]}

Ortuzar-Pasalodos, Ariana ^{[7
]}

Gonzalez-Gascon-y-Marin, Isabel Teresa ^{[8
]}

Moreno, Gemma ^{[9
]}

Arquero-Portero, Teresa ^{[10
]}

Moreno-Carbonell, Marta ^{[1
]}

Revilla, Nuria ^{[10
]}

机构：

[1] Hosp Gen Univ Gregorio Maranon, Inst Invest Gregorio Maranon, Hematol, Madrid, Spain

[2] Hosp Univ Puerta Hierro, Hematol, Madrid, Spain

[3] Hosp Univ Principe Asturias, Hematol, Madrid, Spain

[4] Hosp Univ Getafe, Madrid, Spain

[5] Hosp Univ La Paz, Hematol, Madrid, Spain

[6] Hosp Univ 12 Octubre, Hematol, Madrid, Spain

[7] Hosp Univ Rey Juan Carlos, Hematol, Madrid, Spain

[8] Hosp Univ Infanta Leonor, Hematol, Madrid, Spain

[9] Hosp Univ Ramon & Cajal, Hematol, Madrid, Spain

[10] Hosp Univ Fdn Jimenez Diaz, Inst Invest Fdn Jimenez Diaz IIS FJD, Hematol, Madrid, Spain

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2025年 / 206卷 / 02期

关键词：

avatrombopag; immune thrombocytopenia; ITP; TPO-RA;

D O I：

10.1111/bjh.19975

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Immune thrombocytopenia (ITP) is a rare acquired disorder where thrombopoietin-receptor agonists have become mainstays of ITP treatment. With the recent approval of avatrombopag (AVA), real-world studies are essential to evaluate its efficacy and safety. Our study of 66 adult ITP patients treated with AVA showed a high response rate. After starting AVA, 74.2% did not require rescue medications, with minimal adverse effects. Additionally, 56.0% of patients reduced other ITP medications, and all patients aged >= 65 years responded to AVA. Results should be confirmed in larger studies, but AVA appears to be an effective and safe treatment for ITP patients.

引用

页码：652 / 656

页数：5

共 50 条

[41] Can COVID-19 Increase Platelet in Adult Immune Thrombocytopenia During the TPO-RA Administration? A Real-World Observational Study
Wang, Xiaoyu
Zhu, Yingqiao
Liu, Dan
Zhu, Lijun
Tong, Juan
Zheng, Changcheng
JOURNAL OF BLOOD MEDICINE, 2024, 15 : 217 - 225
[42] First line treatment of adult patients with primary immune thrombocytopenia: a real-world study
Wang, Liang
Xu, Lei
Hao, Hongyuan
Jansen, A. J. Gerard
Liu, Guoqiang
Li, Honglei
Liu, Xinguang
Zhao, Yajing
Peng, Jun
Hou, Ming
PLATELETS, 2020, 31 (01) : 55 - 61
[43] Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI)
Cooper, Nichola
Cuker, Adam
Bonner, Nicola
Ghanima, Waleed
Provan, Drew
Morgan, Mervyn
Taylor, Barbara
D'Alessio, Denise
Arnold, Donald
Viana, Ricardo
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (04) : 759 - 766
[44] Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review
Yoshiyuki Kurata
Kingo Fujimura
Masataka Kuwana
Yoshiaki Tomiyama
Mitsuru Murata
International Journal of Hematology, 2011, 93 : 329 - 335
[45] A real-world study of immune thrombocytopenia management during the COVID-19 pandemic in the UK
Rampotas, Alexandros
Watson, Edmund
Burton, Kieran
Hill, Quentin A.
Pavord, Sue
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (02) : 351 - 355
[46] Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review
Kurata, Yoshiyuki
Fujimura, Kingo
Kuwana, Masataka
Tomiyama, Yoshiaki
Murata, Mitsuru
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (03) : 329 - 335
[47] Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study
Lafaurie, Margaux
Maquet, Julien
Baricault, Berangere
Ekstrand, Charlotta
Christiansen, Christian F.
Linder, Marie
Bahmanyar, Shahram
Norgaard, Mette
Sailler, Laurent
Lapeyre-Mestre, Maryse
Sommet, Agnes
Moulis, Guillaume
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (03) : 456 - 465
[48] Health-related quality of life in children with chronic immune thrombocytopenia treated with eltrombopag in the PETIT study
Grainger, John D.
Blanchette, Victor S.
Grotzinger, Kelly M.
Roy, Anuja
Bussel, James B.
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (01) : 102 - 106
[49] Reliability and validity of the Amharic version of immune thrombocytopenia life quality index tool for assessment of the health-related quality of life in Ethiopian patients of immune thrombocytopenia: Cross-sectional study
Beyene, Dessale Abate
Sisay, Eskinder Ayalew
Fentie, Atalay Mulu
Gebremedhin, Amha
SAGE OPEN MEDICINE, 2023, 11
[50] The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study
Mahevas, Matthieu
Fain, Olivier
Ebbo, Mikael
Roudot-Thoraval, Francoise
Limal, Nicolas
Khellaf, Mehdi
Schleinitz, Nicolas
Bierling, Philippe
Languille, Laeticia
Godeau, Bertrand
Michel, Marc
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (06) : 865 - 869

← 1 2 3 4 5 →